Horizon Quantum (HQ) reported earnings of $0.55 per share for the September quarter, on no revenue. That figure is diluted EPS; the release highlights basic EPS of $0.61. The profit has almost nothing to do with operations. Net income of $33.4 million included a $43.1 million non-cash gain from remeasuring warrant liabilities. The gain arose because Horizon's share price fell during the quarter, which reduced the fair value of those warrants. Strip it out and the picture reverses. The operating loss more than doubled to $10.5 million from $4.9 million a year earlier, and the Adjusted EBITDA loss widened to $6.3 million from $3.0 million. That is the central tension: the headline swing from a $5.2 million year-ago loss to a sizable profit masks a business that is spending faster than management had signaled.

The quality of the quarter deserves scrutiny on several fronts. There is no consensus estimate to measure against, and no revenue to anchor growth comparisons. Reported earnings will also keep swinging with the stock. The $32.4 million in warrant liabilities still on the balance sheet will be remeasured every quarter, and Q2 showed the opposite effect, a $108.3 million non-cash charge. Year to date, Horizon has lost $85.4 million, or $1.73 per share. For a pre-revenue company, the meaningful numbers are operating expense, cash burn and runway, and all three moved the wrong way.

The call made the cost trajectory hard to ignore. Total operating expense rose from $6.5 million in Q1 to $7.2 million in Q2, then jumped to $10.5 million in Q3. That jump came after the CFO had described the Q2 level as a reasonable base. A meaningful part of the increase was share-based compensation, which totaled roughly $3.8 million across R&D and G&A in Q3. Even so, cash costs are rising:

• **Adjusted EBITDA loss**, which excludes stock compensation, widened from $4.1 million to $5.5 million to $6.3 million over the three quarters.
• **Operating cash burn** climbed from $4.2 million to $5.1 million to $7.2 million.
• **Headcount growth** slowed to 5% sequentially, reaching 60 employees, which suggests the spending increase reflects pay and public-company costs as much as hiring.

Cash fell $10.5 million sequentially to $102.8 million. Q2 had been lifted by about $27.5 million of warrant exercises, and no comparable inflow arrived this quarter. Management also cited inconsistent cash figures on the call ($102.8 million versus $100 million), a small but unhelpful detail.

The technical story, by contrast, kept building. Horizon completed pulse-level integration of its Triple Alpha development environment with OQC's 32-qubit Toshiko processor. That extends a hardware roster that added Quantum Machines in Q2 and Alice & Bob and AQT in Q1. The company also demonstrated multiplexed crosstalk characterization on Rigetti's 108-qubit Cepheus, cutting roughly 5,000 pairwise experiments to seven. Perhaps the most commercially relevant comment was the CEO's statement that "level four" language, meaning hardware vendors offering Triple Alpha to their own users, is now appearing in a number of contracts. Management again said partner demand exceeds team capacity. None of this has yet produced revenue, and there is still no formal guidance.

The forward-looking developments cut both ways. The non-binding letter of intent to acquire Entropica Labs for about $27 million in Class A shares would add error-correction and fault-tolerance capability. It is still subject to diligence and definitive agreements, and it would dilute shareholders. It also marks a strategic pivot after Q2 commentary that M&A was not a primary strategy. Separately, payments for the IonQ 256-qubit system in Dublin will run through capex, which already reached $11.0 million year to date. Bears have legitimate ammunition here: operating burn is rising, capex is still ahead, and acquisitions are being funded with stock. The update on the Beryllium product was qualitative only, with no expansion of early access.

Market context is limited, and no current investor-sentiment reading is available. Shares opened at $13.08 after the prior report, already below the 200-day moving average of $14.84. The warrant gain itself confirms that the stock declined further during the quarter. So the market has been discounting the story even as technical milestones accumulated.

The bottom line is that Horizon's GAAP profit is an artifact of its own falling share price, not evidence of operating progress. The engineering and partner-integration narrative remains credible and arguably improving. But costs are now running well ahead of management's earlier framing, cash burn is accelerating, and the next leg of growth leans on dilutive M&A and heavy capex. With more than $100 million in cash, the runway is not an immediate concern. What investors need is a demonstrable path from "level four" partner language to actual revenue.